Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.
暂无分享，去创建一个
A. Ravaud | S. Culine | J. Machiels | G. Deplanque | S. Oudard | S. Foulon | G. Gravis | F. Joly | M. Baciuchka | C. Théodore | D. Pouessel | K. Fizazi | P. Beuzeboc | J. Ferrero | C. Linassier | J. Boher | M. Soulié | B. Laguerre | G. Bousquet | N. Tubiana-Mathieu | I. Krakowski | I. Latorzeff | J. Dauba | F. Priou | J. Eymard | J. Berdah | M. Habibian | S. Zanetta | F. Rolland | L. Mourey | P. Lavaud | E. Suc | C. E. Kouri | R. Delva | C. Platini | A. Hasbini | Gabrielle Tergemina-Clain | Clémence Legoupil | C. Kouri | M. Soulie